Marjolijn Lub-de Hooge
Marjolijn Lub-de Hooge
University Medical Center Groningen
Dirección de correo verificada de
Citado por
Citado por
Biodistribution of 89Zr‐trastuzumab and PET Imaging of HER2‐Positive Lesions in Patients With Metastatic Breast Cancer
EC Dijkers, TH Oude Munnink, JG Kosterink, AH Brouwers, PL Jager, ...
Clinical Pharmacology & Therapeutics 87 (5), 586-592, 2010
89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer
F Bensch, EL van der Veen, MN Lub-de Hooge, A Jorritsma-Smit, ...
Nature medicine 24 (12), 1852-1858, 2018
Indium-111–labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer
PJ Perik, MN Lub-De Hooge, JA Gietema, WTA van der Graaf, ...
Journal of clinical oncology 24 (15), 2276-2282, 2006
In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft
WB Nagengast, EG De Vries, GA Hospers, NH Mulder, JR De Jong, ...
Journal of Nuclear Medicine 48 (8), 1313-1319, 2007
Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging
ECF Dijkers, JGW Kosterink, AP Rademaker, LR Perk, ...
Journal of nuclear medicine 50 (6), 974-981, 2009
Immuno-PET: a navigator in monoclonal antibody development and applications
GAMS Van Dongen, GWM Visser, MN Lub-de Hooge, EG De Vries, ...
The oncologist 12 (12), 1379-1389, 2007
Preclinical characterisation of 111In‐DTPA‐trastuzumab
MN Lub‐de Hooge, JGW Kosterink, PJ Perik, H Nijnuis, L Tran, J Bart, ...
British journal of pharmacology 143 (1), 99-106, 2004
A review of bispecific antibodies and antibody constructs in oncology and clinical challenges
FV Suurs, MN Lub-de Hooge, EGE de Vries, DJA de Groot
Pharmacology & therapeutics 201, 103-119, 2019
Tumor-specific uptake of fluorescent bevacizumab–IRDye800CW microdosing in patients with primary breast cancer: a phase I feasibility study
LE Lamberts, M Koch, JS de Jong, ALL Adams, J Glatz, MEG Kranendonk, ...
Clinical Cancer Research 23 (11), 2730-2741, 2017
89Zr-bevacizumab PET imaging in primary breast cancer
SBM Gaykema, AH Brouwers, MN Lub-de Hooge, RG Pleijhuis, ...
Journal of nuclear medicine 54 (7), 1014-1018, 2013
Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis
BPC Hazenberg, MH van Rijswijk, DA Piers, MN Lub-de Hooge, ...
The American journal of medicine 119 (4), 355. e15-355. e24, 2006
111Indium-trastuzumab visualises myocardial human epidermal growth factor receptor 2 expression shortly after anthracycline treatment but not during heart failure: a clue to …
MA De Korte, EGE De Vries, MN Lub-de Hooge, PL Jager, JA Gietema, ...
European Journal of Cancer 43 (14), 2046-2051, 2007
89Zr-bevacizumab PET of early antiangiogenic tumor response to treatment with HSP90 inhibitor NVP-AUY922
WB Nagengast, MA de Korte, THO Munnink, H Timmer-Bosscha, ...
Journal of Nuclear Medicine 51 (5), 761-767, 2010
Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery
M Kijanka, FJ Warnders, M El Khattabi, M Lub-de Hooge, GM van Dam, ...
European journal of nuclear medicine and molecular imaging 40, 1718-1729, 2013
89Zr-bevacizumab PET visualizes heterogeneous tracer accumulation in tumor lesions of renal cell carcinoma patients and differential effects of antiangiogenic treatment
SF Oosting, AH Brouwers, SC van Es, WB Nagengast, THO Munnink, ...
Journal of Nuclear Medicine 56 (1), 63-69, 2015
VEGF-PET imaging is a noninvasive biomarker showing differential changes in the tumor during sunitinib treatment
WB Nagengast, MN Lub-de Hooge, SF Oosting, WFA den Dunnen, ...
Cancer research 71 (1), 143-153, 2011
89Zr-trastuzumab and 89Zr-bevacizumab PET to Evaluate the Effect of the HSP90 Inhibitor NVP-AUY922 in Metastatic Breast Cancer Patients
SBM Gaykema, CP Schröder, J Vitfell-Rasmussen, S Chua, ...
Clinical Cancer Research 20 (15), 3945-3954, 2014
Bevacizumab-induced normalization of blood vessels in tumors hampers antibody uptake
M Arjaans, TH Oude Munnink, SF Oosting, ...
Cancer research 73 (11), 3347-3355, 2013
Antibody positron emission tomography imaging in anticancer drug development
LE Lamberts, SP Williams, AGT Terwisscha van Scheltinga, ...
Journal of Clinical Oncology 33 (13), 1491-1504, 2015
89Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up
F Bensch, AH Brouwers, MN Lub-de Hooge, JR de Jong, B van der Vegt, ...
European journal of nuclear medicine and molecular imaging 45, 2300-2306, 2018
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20